期刊论文详细信息
Nutrition & Metabolism
A high calcium diet containing nonfat dry milk reduces weight gain and associated adipose tissue inflammation in diet-induced obese mice when compared to high calcium alone
Sean H Adams1  Pieter J Oort1  Josephine B Drayton2  Tamara N Dunn3  Anthony P Thomas3 
[1] Obesity & Metabolism Research Unit, United States Department of Agriculture-Agricultural Research Service Western Human Nutrition Research Center, 430 W. Health Sciences Dr., Davis, CA 95616, USA;Department of Animal Science, University of California, One Shields Ave., Davis, CA 95616, USA;Department of Nutrition, University of California, One Shields Avenue, Davis, CA, USA
关键词: inflammation;    obesity;    dairy;    calcium;    Calcitriol;   
Others  :  820135
DOI  :  10.1186/1743-7075-9-3
 received in 2011-11-18, accepted in 2012-01-23,  发布年份 2012
PDF
【 摘 要 】

Background

High dietary calcium (Ca) is reported to have anti-obesity and anti-inflammatory properties. Evidence for these properties of dietary Ca in animal models of polygenic obesity have been confounded by the inclusion of dairy food components in experimental diets; thus, effect of Ca per se could not be deciphered. Furthermore, potential anti-inflammatory actions of Ca in vivo could not be dissociated from reduced adiposity.

Methods

We characterized adiposity along with metabolic and inflammatory phenotypes in diet-induced obese (DIO) mice fed 1 of 3 high fat diets (45% energy) for 12 wk: control (n = 29), high-Ca (n = 30), or high-Ca + nonfat dry milk (NFDM) (n = 30).

Results

Mice fed high-Ca + NFDM had reduced body weight and adiposity compared to high-Ca mice (P < 0.001). Surprisingly, the high-Ca mice had increased adiposity compared to lower-Ca controls (P < 0.001). Hyperphagia and increased feed efficiency contributed to obesity development in high-Ca mice, in contrast to NFDM mice that displayed significantly reduced weight gain despite higher energy intake compared to controls (P < 0.001). mRNA markers of macrophages (e.g., CD68, CD11d) strongly correlated with body weight in all diet treatment groups, and most treatment differences in WAT inflammatory factor mRNA abundances were lost when controlling for body weight gain as a covariate.

Conclusions

The results indicate that high dietary Ca is not sufficient to dampen obesity-related phenotypes in DIO mice, and in fact exacerbates weight gain and hyperphagia. The data further suggest that putative anti-obesity properties of dairy emanate from food components beyond Ca.

【 授权许可】

   
2012 Thomas et al; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140712025332513.pdf 373KB PDF download
Figure 4. 61KB Image download
Figure 3. 53KB Image download
Figure 2. 46KB Image download
Figure 1. 78KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Zemel MB: The role of dairy foods in weight management. J Am Coll Nutr 2005, 24:537S-546S.
  • [2]Van Loan M: The role of dairy foods and dietary calcium in weight management. J Am Coll Nutr 2009, 28(Suppl 1):120S-129S.
  • [3]Lanou AJ, Barnard ND: Dairy and weight loss hypothesis: an evaluation of the clinical trials. Nutr Rev 2008, 66:272-279.
  • [4]Papakonstantinou E, Flatt WP, Huth PJ, Harris RB: High dietary calcium reduces body fat content, digestibility of fat, and serum vitamin D in rats. Obes Res 2003, 11:387-394.
  • [5]Sun X, Zemel MB: Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in Ap2-agouti transgenic mice. J Nutr 2004, 134:3054-3060.
  • [6]Pilvi TK, Korpela R, Huttunen M, Vapaatalo H, Mervaala EM: High-calcium diet with whey protein attenuates body-weight gain in high-fat-fed C57Bl/6J mice. Br J Nutr 2007, 98:900-907.
  • [7]Parra P, Bruni G, Palou A, Serra F: Dietary calcium attenuation of body fat gain during high-fat feeding in mice. J Nutr Biochem 2008, 19:109-117.
  • [8]Christensen R, Lorenzen JK, Svith CR, Bartels EM, Melanson EL, Saris WH, Tremblay A, Astrup A: Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev 2009, 10:475-486.
  • [9]Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC: Regulation of adiposity by dietary calcium. Faseb J 2000, 14:1132-1138.
  • [10]Shi H, Norman AW, Okamura WH, Sen A, Zemel MB: 1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. Faseb J 2001, 15:2751-2753.
  • [11]Zemel MB: Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr 2002, 21:146S-151S.
  • [12]Olefsky JM, Glass CK: Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219-246.
  • [13]Fernandez-Veledo S, Nieto-Vazquez I, Vila-Bedmar R, Garcia-Guerra L, Alonso-Chamorro M, Lorenzo M: Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach. Arch Physiol Biochem 2009, 115:227-239.
  • [14]Zeyda M, Stulnig TM: Obesity, inflammation, and insulin resistance--a mini-review. Gerontology 2009, 55:379-386.
  • [15]Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
  • [16]Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
  • [17]Fain JN: Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006, 74:443-477.
  • [18]Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Gyori G, Zlabinger GJ, Stulnig TM: Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) 2007, 31:1420-1428.
  • [19]Sun X, Zemel MB: Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J Nutr Biochem 2008, 19:392-399.
  • [20]Sun X, Zemel MB: Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity (Silver Spring) 2007, 15:340-348.
  • [21]Zemel MB, Sun X: Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans. J Nutr 2008, 138:1047-1052.
  • [22]Zemel MB: Proposed role of calcium and dairy food components in weight management and metabolic health. Phys Sportsmed 2009, 37:29-39.
  • [23]Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN: Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988, 37:1163-1167.
  • [24]Thomas AP, Dunn TN, Oort PJ, Grino M, Adams SH: Inflammatory Phenotyping Identifies CD11d as a Gene Markedly Induced in White Adipose Tissue in Obese Rodents and Women. J Nutr 2011, 141:1172-1180.
  • [25]Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
  • [26]Zemel MB, Sun X: Calcitriol and energy metabolism. Nutr Rev 2008, 66:S139-146.
  • [27]Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA: IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996, 4:329-336.
  • [28]Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, et al.: Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994, 264:965-968.
  • [29]Tagaya Y, Kurys G, Thies TA, Losi JM, Azimi N, Hanover JA, Bamford RN, Waldmann TA: Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci USA 1997, 94:14444-14449.
  • [30]Nong YH, Titus RG, Ribeiro JM, Remold HG: Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 1989, 143:45-49.
  • [31]Gomes RN, Castro-Faria-Neto HC, Bozza PT, Soares MB, Shoemaker CB, David JR, Bozza MT: Calcitonin gene-related peptide inhibits local acute inflammation and protects mice against lethal endotoxemia. Shock 2005, 24:590-594.
  • [32]Cote GJ, Rogers DG, Huang ES, Gagel RF: The effect of 1,25-dihydroxyvitamin D3 treatment on calcitonin and calcitonin gene-related peptide mRNA levels in cultured human thyroid C-cells. Biochem Biophys Res Commun 1987, 149:239-243.
  • [33]DiPette DJ, Westlund KN, Holland OB: Dietary calcium modulates spinal cord content of calcitonin gene-related peptide in the rat. Neurosci Lett 1988, 95:335-340.
  • [34]Sun X, Zemel MB: Dietary calcium regulates ROS production in aP2-agouti transgenic mice on high-fat/high-sucrose diets. Int J Obes (Lond) 2006, 30:1341-1346.
  • [35]Eller LK, Reimer RA: Dairy protein attenuates weight gain in obese rats better than whey or casein alone. Obesity (Silver Spring) 18:704-711.
  • [36]Narvaez CJ, Matthews D, Broun E, Chan M, Welsh J: Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 2009, 150:651-661.
  • [37]Roca P, Rodriguez AM, Oliver P, Bonet ML, Quevedo S, Pico C, Palou A: Brown adipose tissue response to cafeteria diet-feeding involves induction of the UCP2 gene and is impaired in female rats as compared to males. Pflugers Arch 1999, 438:628-634.
  • [38]Quinn LS: Interleukin-15: a muscle-derived cytokine regulating fat-to-lean body composition. J Anim Sci 2008, 86:E75-83.
  • [39]Shertzer HG, Woods SE, Krishan M, Genter MB, Pearson KJ: Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet. J Nutr 2011, 141:582-587.
  • [40]Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH: Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 2007, 56:1647-1654.
  • [41]Sun X, Zemel MB: Leucine modulation of mitochondrial mass and oxygen consumption in skeletal muscle cells and adipocytes. Nutr Metab (Lond) 2009, 6:26. BioMed Central Full Text
  • [42]Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P: mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007, 450:736-740.
  • [43]Owen OE, Kalhan SC, Hanson RW: The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem 2002, 277:30409-30412.
  • [44]Saito T: Antihypertensive peptides derived from bovine casein and whey proteins. Adv Exp Med Biol 2008, 606:295-317.
  • [45]Yvan-Charvet L, Quignard-Boulange A: Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int 2011, 79:162-168.
  • [46]Gahmberg CG, Valmu L, Fagerholm S, Kotovuori P, Ihanus E, Tian L, Pessa-Morikawa T: Leukocyte integrins and inflammation. Cell Mol Life Sci 1998, 54:549-555.
  • [47]Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R, Bouloumie A: From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53:1285-1292.
  • [48]Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, Bouloumie A: Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006, 49:744-747.
  • [49]Shaul ME, Bennett G, Strissel KJ, Greenberg AS, Obin MS: Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet--induced obesity in mice. Diabetes 2010, 59:1171-1181.
  文献评价指标  
  下载次数:45次 浏览次数:19次